Tongue hyperpigmentation during interferon-alpha and ribavirin therapy

被引：6
|
作者：
Aguayo-Leiva, Ingrid [1 ]
Perez, Bibiana [1 ]
Salguero, Irene [1 ]
Jaen, Pedro [1 ]
机构：
[1] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2009年 / 19卷 / 03期
关键词：
CHRONIC HEPATITIS-C; VIRUS;
D O I：
10.1684/ejd.2009.0665
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：291 / 292
页数：3
相关论文
共 50 条
  • [31] Autoimmune thyroid diseases in patients with chronic hepatitis C treated by pegylated interferon-alpha and ribavirin - A prospective study
    Ruzic, Maja
    Fabri, Milotka
    Medic-Stojanoska, Milica
    Bajkin, Ivana
    Turkulov, Vesna
    Abenavoli, Ludovico
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2017, 145 (1-2) : 43 - 48
  • [32] Ischemic colitis during interferon-alpha treatment for chronic active hepatitis C
    Tada, H
    Saitoh, S
    Nakagawa, Y
    Hirana, H
    Morimoto, M
    Shima, T
    Shimamoto, K
    Okanoue, T
    Kashima, K
    JOURNAL OF GASTROENTEROLOGY, 1996, 31 (04) : 582 - 584
  • [33] Human leucocyte interferon-alpha in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-alpha: A randomized controlled trial
    Gaeta, GB
    DiVirgilio, D
    Russo, G
    Stornaiuolo, G
    Nicolella, U
    Colella, F
    Grimaldi, M
    Pasquale, G
    Giusti, G
    JOURNAL OF VIRAL HEPATITIS, 1997, 4 (03) : 209 - 214
  • [34] Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha
    Barbaro, G
    Di Lorenzo, G
    Soldini, M
    Giancaspro, G
    Pellicelli, A
    Grisorio, B
    Babarini, G
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (09) : 928 - 933
  • [35] In Vivo Interferon-Alpha/Ribavirin Treatment Modulates Vγ9Vδ2 T-Cell Function During Chronic HCV Infection
    Cimini, Eleonora
    Bonnafous, Cecile
    Sicard, Helene
    Vlassi, Chrysoula
    D'Offizi, Gianpiero
    Capobianchi, Maria R.
    Martini, Federico
    Agrati, Chiara
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (03): : 136 - 141
  • [36] Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin
    Oliveira, Isabela S.
    Carvalho, Lucas P.
    Schinoni, Maria Isabel
    Parana, Raymundo
    Atta, Ajax M.
    Sousa Atta, Maria Luiza B.
    MICROBIAL PATHOGENESIS, 2016, 91 : 155 - 160
  • [37] Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin
    Striki, A.
    Manolakopoulos, S.
    Deutsch, M.
    Mela, M.
    Kalafateli, M.
    Schini, M.
    Anagnostou, O.
    Triantos, C.
    Andreadis, I.
    Ketikoglou, I.
    Papatheodoridis, G.
    Pectasides, D.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (09) : 624 - 632
  • [38] A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
    Demiraslan, Hayati
    Aygen, Bilgehan
    Yildiz, Orhan
    Soyuer, Isin
    Gokahmetoglu, Selma
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01): : 12 - 22
  • [39] Interferon-alpha therapy for individuals with normal serum alanine aminotransferase levels before treatment
    Orito, E
    Mizokami, M
    Suzuki, K
    Ohba, K
    Ohno, T
    Mizuno, M
    Iijima, Y
    Saito, H
    Nemoto, A
    Nukuta, N
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (01) : 58 - 61
  • [40] A randomized trial to assess the efficacy of interferon-alpha daily in combination with ribavirin in the treatment of naive patients with chronic hepatitis C
    Tassopoulos, NC
    Ketikoglou, I
    Tsantoulas, D
    Raptopoulou, M
    Hatzis, G
    Vafiadis, I
    Sidiropoulos, L
    Kanatakis, S
    Anagnostopoulos, G
    Sypsa, V
    Hatzakis, A
    JOURNAL OF VIRAL HEPATITIS, 2003, 10 (05) : 383 - 389
12345